Smith Ernest S. has filed 3 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 1341 shares of VACCINEX, INC. ($VCNX) on March 21, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 21, 2024 | VACCINEX, INC. | $VCNX | Smith Ernest S. | SVP, Research & CSO | A | Stock Option (Right to Buy) | 1341 | $0.00 | 1,341.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2024 | VACCINEX, INC. | $VCNX | Smith Ernest S. | SVP, Research & CSO | A | Stock Option (Right to Buy) | 1341 | $0.00 | 1,966.0000 | 0 | 214.56% | 0.00% |
| March 31, 2023 | VACCINEX, INC. | $VCNX | Smith Ernest S. | SVP, Research & CSO | A | Stock Option (Right to Buy) | 40000 | $0.00 | 131,839.0000 | 0 | 43.55% | 0.00% |